ID   DPOLQ_HUMAN             Reviewed;        2590 AA.
AC   O75417; O95160; Q6VMB5;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   08-MAR-2011, sequence version 2.
DT   12-APR-2017, entry version 132.
DE   RecName: Full=DNA polymerase theta {ECO:0000303|PubMed:10395804, ECO:0000303|PubMed:14576298, ECO:0000312|HGNC:HGNC:9186};
DE            EC=2.7.7.7 {ECO:0000269|PubMed:14576298, ECO:0000269|PubMed:22135286};
DE   AltName: Full=DNA polymerase eta {ECO:0000303|Ref.4};
GN   Name=POLQ {ECO:0000303|PubMed:10395804, ECO:0000303|PubMed:14576298,
GN   ECO:0000312|HGNC:HGNC:9186}; Synonyms=POLH {ECO:0000303|Ref.4};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Spleen;
RX   PubMed=10395804; DOI=10.1006/geno.1999.5843;
RA   Sharief F.S., Vojta P.J., Ropp P.A., Copeland W.C.;
RT   "Cloning and chromosomal mapping of the human DNA polymerase theta
RT   (POLQ), the eighth human DNA polymerase.";
RL   Genomics 59:90-96(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   AND CATALYTIC ACTIVITY.
RX   PubMed=14576298; DOI=10.1093/nar/gkg814;
RA   Seki M., Marini F., Wood R.D.;
RT   "POLQ (Pol theta), a DNA polymerase and DNA-dependent ATPase in human
RT   cells.";
RL   Nucleic Acids Res. 31:6117-6126(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1435-2590.
RA   Harris P.V., Kaelin C.B., Burtis K.C.;
RT   "Catalytic activity of Pol eta, a new human DNA polymerase related to
RT   the bacterial DNA polymerase I family and Drosophila Mus308.";
RL   Submitted (JAN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   FUNCTION.
RX   PubMed=18503084; DOI=10.1093/nar/gkn310;
RA   Arana M.E., Seki M., Wood R.D., Rogozin I.B., Kunkel T.A.;
RT   "Low-fidelity DNA synthesis by human DNA polymerase theta.";
RL   Nucleic Acids Res. 36:3847-3856(2008).
RN   [6]
RP   FUNCTION, AND MUTAGENESIS OF 2540-ASP-GLU-2541.
RX   PubMed=19188258; DOI=10.1093/nar/gkp035;
RA   Prasad R., Longley M.J., Sharief F.S., Hou E.W., Copeland W.C.,
RA   Wilson S.H.;
RT   "Human DNA polymerase theta possesses 5'-dRP lyase activity and
RT   functions in single-nucleotide base excision repair in vitro.";
RL   Nucleic Acids Res. 37:1868-1877(2009).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-990, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [8]
RP   INVOLVEMENT IN BC.
RX   PubMed=20700469;
RA   Higgins G.S., Harris A.L., Prevo R., Helleday T., McKenna W.G.,
RA   Buffa F.M.;
RT   "Overexpression of POLQ confers a poor prognosis in early breast
RT   cancer patients.";
RL   Oncotarget 1:175-184(2010).
RN   [9]
RP   INVOLVEMENT IN BC.
RX   PubMed=20624954; DOI=10.1073/pnas.0910759107;
RA   Lemee F., Bergoglio V., Fernandez-Vidal A., Machado-Silva A.,
RA   Pillaire M.J., Bieth A., Gentil C., Baker L., Martin A.L., Leduc C.,
RA   Lam E., Magdeleine E., Filleron T., Oumouhou N., Kaina B., Seki M.,
RA   Grimal F., Lacroix-Triki M., Thompson A., Roche H., Bourdon J.C.,
RA   Wood R.D., Hoffmann J.S., Cazaux C.;
RT   "DNA polymerase theta up-regulation is associated with poor survival
RT   in breast cancer, perturbs DNA replication, and promotes genetic
RT   instability.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:13390-13395(2010).
RN   [10]
RP   FUNCTION.
RX   PubMed=21050863; DOI=10.1016/j.jmb.2010.10.041;
RA   Hogg M., Seki M., Wood R.D., Doublie S., Wallace S.S.;
RT   "Lesion bypass activity of DNA polymerase theta (POLQ) is an intrinsic
RT   property of the pol domain and depends on unique sequence inserts.";
RL   J. Mol. Biol. 405:642-652(2011).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=22135286; DOI=10.1093/nar/gkr1102;
RA   Hogg M., Sauer-Eriksson A.E., Johansson E.;
RT   "Promiscuous DNA synthesis by human DNA polymerase theta.";
RL   Nucleic Acids Res. 40:2611-2622(2012).
RN   [12]
RP   INVOLVEMENT IN BC.
RX   PubMed=25409685; DOI=10.1186/1471-2407-14-850;
RA   Brandalize A.P., Schueler-Faccini L., Hoffmann J.S., Caleffi M.,
RA   Cazaux C., Ashton-Prolla P.;
RT   "A DNA repair variant in POLQ (c.-1060A > G) is associated to
RT   hereditary breast cancer patients: a case-control study.";
RL   BMC Cancer 14:850-850(2014).
RN   [13]
RP   FUNCTION, AND MUTAGENESIS OF 2540-ASP-GLU-2541.
RX   PubMed=24648516; DOI=10.1074/jbc.M114.556977;
RA   Yoon J.H., Roy Choudhury J., Park J., Prakash S., Prakash L.;
RT   "A role for DNA polymerase theta in promoting replication through
RT   oxidative DNA lesion, thymine glycol, in human cells.";
RL   J. Biol. Chem. 289:13177-13185(2014).
RN   [14]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH ORC2 AND ORC4.
RX   PubMed=24989122; DOI=10.1038/ncomms5285;
RA   Fernandez-Vidal A., Guitton-Sert L., Cadoret J.C., Drac M., Schwob E.,
RA   Baldacci G., Cazaux C., Hoffmann J.S.;
RT   "A role for DNA polymerase theta in the timing of DNA replication.";
RL   Nat. Commun. 5:4285-4285(2014).
RN   [15]
RP   FUNCTION, INTERACTION WITH RAD51, AND SUBCELLULAR LOCATION.
RX   PubMed=25642963; DOI=10.1038/nature14184;
RA   Ceccaldi R., Liu J.C., Amunugama R., Hajdu I., Primack B.,
RA   Petalcorin M.I., O'Connor K.W., Konstantinopoulos P.A., Elledge S.J.,
RA   Boulton S.J., Yusufzai T., D'Andrea A.D.;
RT   "Homologous-recombination-deficient tumours are dependent on Poltheta-
RT   mediated repair.";
RL   Nature 518:258-262(2015).
RN   [16]
RP   FUNCTION, SUBUNIT, AND DOMAIN.
RX   PubMed=25643323; DOI=10.1038/nsmb.2961;
RA   Kent T., Chandramouly G., McDevitt S.M., Ozdemir A.Y., Pomerantz R.T.;
RT   "Mechanism of microhomology-mediated end-joining promoted by human DNA
RT   polymerase theta.";
RL   Nat. Struct. Mol. Biol. 22:230-237(2015).
CC   -!- FUNCTION: DNA polymerase that promotes microhomology-mediated end-
CC       joining (MMEJ), an alternative non-homologous end-joining (NHEJ)
CC       machinery triggered in response to double-strand breaks in DNA
CC       (PubMed:25642963, PubMed:25643323). MMEJ is an error-prone repair
CC       pathway that produces deletions of sequences from the strand being
CC       repaired and promotes genomic rearrangements, such as telomere
CC       fusions, some of them leading to cellular transformation
CC       (PubMed:25642963, PubMed:25643323). POLQ acts as an inhibitor of
CC       homology-recombination repair (HR) pathway by limiting RAD51
CC       accumulation at resected ends (PubMed:25642963). POLQ-mediated
CC       MMEJ may be required to promote the survival of cells with a
CC       compromised HR repair pathway, thereby preventing genomic havoc by
CC       resolving unrepaired lesions (By similarity). The polymerase acts
CC       by binding directly the 2 ends of resected double-strand breaks,
CC       allowing microhomologous sequences in the overhangs to form base
CC       pairs. It then extends each strand from the base-paired region
CC       using the opposing overhang as a template. Requires partially
CC       resected DNA containing 2 to 6 base pairs of microhomology to
CC       perform MMEJ (PubMed:25643323). The polymerase activity is highly
CC       promiscuous: unlike most polymerases, promotes extension of ssDNA
CC       and partial ssDNA (pssDNA) substrates (PubMed:18503084,
CC       PubMed:21050863, PubMed:22135286). Also exhibits low-fidelity DNA
CC       synthesis, translesion synthesis and lyase activity, and it is
CC       implicated in interstrand-cross-link repair, base excision repair
CC       and DNA end-joining (PubMed:14576298, PubMed:18503084,
CC       PubMed:19188258, PubMed:24648516). Involved in somatic
CC       hypermutation of immunoglobulin genes, a process that requires the
CC       activity of DNA polymerases to ultimately introduce mutations at
CC       both A/T and C/G base pairs (By similarity).
CC       {ECO:0000250|UniProtKB:Q8CGS6, ECO:0000269|PubMed:14576298,
CC       ECO:0000269|PubMed:18503084, ECO:0000269|PubMed:19188258,
CC       ECO:0000269|PubMed:21050863, ECO:0000269|PubMed:22135286,
CC       ECO:0000269|PubMed:24648516, ECO:0000269|PubMed:25642963,
CC       ECO:0000269|PubMed:25643323}.
CC   -!- CATALYTIC ACTIVITY: Deoxynucleoside triphosphate + DNA(n) =
CC       diphosphate + DNA(n+1). {ECO:0000269|PubMed:14576298,
CC       ECO:0000269|PubMed:22135286}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.095 uM for dATP:T {ECO:0000269|PubMed:22135286};
CC         KM=0.622 uM for dATP: abasic site {ECO:0000269|PubMed:22135286};
CC         KM=3.08 uM for dGTP: no template {ECO:0000269|PubMed:22135286};
CC   -!- SUBUNIT: Homomultimer; forms dimers and multimers
CC       (PubMed:25643323). Interacts with RAD51 (PubMed:25642963).
CC       Interacts with ORC2 and ORC4 (PubMed:24989122).
CC       {ECO:0000269|PubMed:24989122, ECO:0000269|PubMed:25642963,
CC       ECO:0000269|PubMed:25643323}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O18475}.
CC       Chromosome {ECO:0000269|PubMed:25642963}. Note=Enriched in
CC       chromatin in response to ultaviolet (UV) light (PubMed:25642963).
CC       Binds to chromatin during early G1 (PubMed:24989122).
CC       {ECO:0000269|PubMed:24989122, ECO:0000269|PubMed:25642963}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O75417-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75417-2; Sequence=VSP_040747, VSP_040748;
CC   -!- TISSUE SPECIFICITY: Highly expressed in testis.
CC       {ECO:0000269|PubMed:14576298}.
CC   -!- DOMAIN: The loop 2 region is involved in the binding of the 2 ends
CC       of resected double-strand breaks and homomultimerization.
CC       {ECO:0000269|PubMed:25643323}.
CC   -!- DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy
CC       originating from breast epithelial tissue. Breast neoplasms can be
CC       distinguished by their histologic pattern. Invasive ductal
CC       carcinoma is by far the most common type. Breast cancer is
CC       etiologically and genetically heterogeneous. Important genetic
CC       factors have been indicated by familial occurrence and bilateral
CC       involvement. Mutations at more than one locus can be involved in
CC       different families or even in the same case.
CC       {ECO:0000269|PubMed:20624954, ECO:0000269|PubMed:20700469,
CC       ECO:0000269|PubMed:25409685}. Note=The gene represented in this
CC       entry may be involved in disease pathogenesis.
CC   -!- SIMILARITY: Belongs to the DNA polymerase type-A family.
CC       {ECO:0000305}.
CC   -!- CAUTION: Was wrongly named DNA polymerase eta (POLH) somne authors
CC       (Ref.4). This protein corresponds to DNA polymerase theta (POLQ)
CC       and should not be confused with DNA polymerase eta (POLH) (AC
CC       Q9Y253). {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD05272.1; Type=Frameshift; Positions=1754; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF052573; AAC33565.1; -; mRNA.
DR   EMBL; AY338826; AAR08421.2; -; mRNA.
DR   EMBL; AC069239; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC079841; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF043628; AAD05272.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS33833.1; -. [O75417-1]
DR   RefSeq; NP_955452.3; NM_199420.3. [O75417-1]
DR   UniGene; Hs.241517; -.
DR   PDB; 4X0P; X-ray; 3.91 A; A/B/C/D=1792-2590.
DR   PDB; 4X0Q; X-ray; 3.90 A; A/B=1819-2590.
DR   PDB; 5A9F; X-ray; 3.20 A; A=67-894.
DR   PDB; 5A9J; X-ray; 3.55 A; A/B/C/D=1-894.
DR   PDB; 5AGA; X-ray; 2.90 A; A=67-894.
DR   PDBsum; 4X0P; -.
DR   PDBsum; 4X0Q; -.
DR   PDBsum; 5A9F; -.
DR   PDBsum; 5A9J; -.
DR   PDBsum; 5AGA; -.
DR   ProteinModelPortal; O75417; -.
DR   SMR; O75417; -.
DR   BioGrid; 115946; 2.
DR   DIP; DIP-61500N; -.
DR   IntAct; O75417; 1.
DR   STRING; 9606.ENSP00000264233; -.
DR   ChEMBL; CHEMBL6025; -.
DR   iPTMnet; O75417; -.
DR   PhosphoSitePlus; O75417; -.
DR   BioMuta; POLQ; -.
DR   EPD; O75417; -.
DR   MaxQB; O75417; -.
DR   PaxDb; O75417; -.
DR   PeptideAtlas; O75417; -.
DR   PRIDE; O75417; -.
DR   DNASU; 10721; -.
DR   Ensembl; ENST00000264233; ENSP00000264233; ENSG00000051341. [O75417-1]
DR   GeneID; 10721; -.
DR   KEGG; hsa:10721; -.
DR   UCSC; uc003eee.5; human. [O75417-1]
DR   CTD; 10721; -.
DR   DisGeNET; 10721; -.
DR   GeneCards; POLQ; -.
DR   H-InvDB; HIX0030706; -.
DR   HGNC; HGNC:9186; POLQ.
DR   HPA; HPA048931; -.
DR   HPA; HPA053359; -.
DR   MIM; 114480; phenotype.
DR   MIM; 604419; gene.
DR   neXtProt; NX_O75417; -.
DR   OpenTargets; ENSG00000051341; -.
DR   PharmGKB; PA33506; -.
DR   eggNOG; KOG0950; Eukaryota.
DR   eggNOG; COG0749; LUCA.
DR   eggNOG; COG1204; LUCA.
DR   GeneTree; ENSGT00640000091272; -.
DR   HOGENOM; HOG000146444; -.
DR   HOVERGEN; HBG005525; -.
DR   InParanoid; O75417; -.
DR   KO; K02349; -.
DR   PhylomeDB; O75417; -.
DR   TreeFam; TF105018; -.
DR   Reactome; R-HSA-5685939; HDR through MMEJ (alt-NHEJ).
DR   GeneWiki; POLQ; -.
DR   GenomeRNAi; 10721; -.
DR   PRO; PR:O75417; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000051341; -.
DR   CleanEx; HS_POLH; -.
DR   CleanEx; HS_POLQ; -.
DR   ExpressionAtlas; O75417; baseline and differential.
DR   Genevisible; O75417; HS.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0051575; F:5'-deoxyribose-5-phosphate lyase activity; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0003684; F:damaged DNA binding; TAS:ProtInc.
DR   GO; GO:0003887; F:DNA-directed DNA polymerase activity; IDA:UniProtKB.
DR   GO; GO:0043142; F:single-stranded DNA-dependent ATPase activity; IDA:UniProtKB.
DR   GO; GO:0006284; P:base-excision repair; IDA:UniProtKB.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; TAS:ProtInc.
DR   GO; GO:0006261; P:DNA-dependent DNA replication; IBA:GO_Central.
DR   GO; GO:0006302; P:double-strand break repair; IDA:UniProtKB.
DR   GO; GO:0097681; P:double-strand break repair via alternative nonhomologous end joining; IDA:UniProtKB.
DR   GO; GO:0000724; P:double-strand break repair via homologous recombination; TAS:Reactome.
DR   GO; GO:2000042; P:negative regulation of double-strand break repair via homologous recombination; IDA:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:UniProtKB.
DR   GO; GO:0016446; P:somatic hypermutation of immunoglobulin genes; ISS:UniProtKB.
DR   InterPro; IPR011545; DEAD/DEAH_box_helicase_dom.
DR   InterPro; IPR019760; DNA-dir_DNA_pol_A_CS.
DR   InterPro; IPR001098; DNA-dir_DNA_pol_A_palm_dom.
DR   InterPro; IPR002298; DNA_polymerase_A.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR012337; RNaseH-like_dom.
DR   Pfam; PF00270; DEAD; 1.
DR   Pfam; PF00476; DNA_pol_A; 1.
DR   Pfam; PF00271; Helicase_C; 1.
DR   PRINTS; PR00868; DNAPOLI.
DR   SMART; SM00487; DEXDc; 1.
DR   SMART; SM00490; HELICc; 1.
DR   SMART; SM00482; POLAc; 1.
DR   SUPFAM; SSF52540; SSF52540; 3.
DR   SUPFAM; SSF53098; SSF53098; 1.
DR   PROSITE; PS00447; DNA_POLYMERASE_A; 1.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS51194; HELICASE_CTER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Chromosome; Coiled coil; Complete proteome; DNA damage; DNA repair;
KW   DNA-directed DNA polymerase; Nucleotide-binding;
KW   Nucleotidyltransferase; Nucleus; Polymorphism; Reference proteome;
KW   Transferase.
FT   CHAIN         1   2590       DNA polymerase theta.
FT                                /FTId=PRO_0000101279.
FT   DOMAIN      102    286       Helicase ATP-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00541}.
FT   DOMAIN      321    554       Helicase C-terminal.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00542}.
FT   NP_BIND     115    122       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00541}.
FT   REGION      847    894       Interaction with RAD51.
FT                                {ECO:0000269|PubMed:25642963}.
FT   REGION     2142   2177       Loop 1. {ECO:0000269|PubMed:21050863}.
FT   REGION     2257   2322       Loop 2. {ECO:0000269|PubMed:21050863,
FT                                ECO:0000269|PubMed:25643323}.
FT   REGION     2491   2535       Loop 3. {ECO:0000269|PubMed:21050863}.
FT   COILED     1655   1716       {ECO:0000255}.
FT   MOTIF       216    219       DEAH box.
FT   MOD_RES     990    990       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ       1    828       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10395804}.
FT                                /FTId=VSP_040747.
FT   VAR_SEQ     829    840       VEVILKNAVPFK -> MNSFLSFPISLC (in isoform
FT                                2). {ECO:0000303|PubMed:10395804}.
FT                                /FTId=VSP_040748.
FT   VARIANT    1056   1056       P -> L (in dbSNP:rs34778629).
FT                                /FTId=VAR_055707.
FT   MUTAGEN    2540   2541       DE->AA: Abolishes DNA polymerase
FT                                activity. {ECO:0000269|PubMed:19188258,
FT                                ECO:0000269|PubMed:24648516}.
FT   CONFLICT     66     66       R -> I (in Ref. 2; AAR08421).
FT                                {ECO:0000305}.
FT   CONFLICT    982    982       T -> R (in Ref. 2; AAR08421).
FT                                {ECO:0000305}.
FT   CONFLICT   2013   2013       L -> F (in Ref. 4; AAD05272).
FT                                {ECO:0000305}.
FT   CONFLICT   2513   2513       Q -> R (in Ref. 1; AAC33565 and 2;
FT                                AAR08421). {ECO:0000305}.
FT   CONFLICT   2547   2547       A -> V (in Ref. 1; AAC33565).
FT                                {ECO:0000305}.
FT   HELIX        71     73       {ECO:0000244|PDB:5AGA}.
FT   HELIX        78     85       {ECO:0000244|PDB:5AGA}.
FT   HELIX        94    101       {ECO:0000244|PDB:5AGA}.
FT   STRAND      102    104       {ECO:0000244|PDB:5AGA}.
FT   TURN        105    108       {ECO:0000244|PDB:5AGA}.
FT   STRAND      111    114       {ECO:0000244|PDB:5AGA}.
FT   HELIX       121    135       {ECO:0000244|PDB:5AGA}.
FT   STRAND      139    146       {ECO:0000244|PDB:5AGA}.
FT   HELIX       147    161       {ECO:0000244|PDB:5AGA}.
FT   HELIX       162    164       {ECO:0000244|PDB:5AGA}.
FT   STRAND      168    171       {ECO:0000244|PDB:5AGA}.
FT   HELIX       181    183       {ECO:0000244|PDB:5AGA}.
FT   STRAND      185    190       {ECO:0000244|PDB:5AGA}.
FT   HELIX       191    203       {ECO:0000244|PDB:5AGA}.
FT   HELIX       207    209       {ECO:0000244|PDB:5AGA}.
FT   STRAND      210    216       {ECO:0000244|PDB:5AGA}.
FT   HELIX       218    221       {ECO:0000244|PDB:5AGA}.
FT   HELIX       229    243       {ECO:0000244|PDB:5AGA}.
FT   HELIX       245    247       {ECO:0000244|PDB:5AGA}.
FT   STRAND      260    266       {ECO:0000244|PDB:5AGA}.
FT   HELIX       271    277       {ECO:0000244|PDB:5AGA}.
FT   STRAND      281    284       {ECO:0000244|PDB:5AGA}.
FT   STRAND      292    298       {ECO:0000244|PDB:5AGA}.
FT   STRAND      301    303       {ECO:0000244|PDB:5AGA}.
FT   STRAND      309    312       {ECO:0000244|PDB:5AGA}.
FT   HELIX       326    335       {ECO:0000244|PDB:5AGA}.
FT   STRAND      340    343       {ECO:0000244|PDB:5AGA}.
FT   HELIX       347    366       {ECO:0000244|PDB:5AGA}.
FT   STRAND      380    383       {ECO:0000244|PDB:5AGA}.
FT   HELIX       384    395       {ECO:0000244|PDB:5AGA}.
FT   HELIX       403    408       {ECO:0000244|PDB:5AGA}.
FT   HELIX       409    411       {ECO:0000244|PDB:5AGA}.
FT   STRAND      413    416       {ECO:0000244|PDB:5AGA}.
FT   HELIX       422    433       {ECO:0000244|PDB:5AGA}.
FT   STRAND      439    442       {ECO:0000244|PDB:5AGA}.
FT   HELIX       444    447       {ECO:0000244|PDB:5AGA}.
FT   STRAND      454    460       {ECO:0000244|PDB:5AGA}.
FT   STRAND      462    464       {ECO:0000244|PDB:5AGA}.
FT   HELIX       471    478       {ECO:0000244|PDB:5AGA}.
FT   TURN        484    486       {ECO:0000244|PDB:5AGA}.
FT   STRAND      490    496       {ECO:0000244|PDB:5AGA}.
FT   STRAND      498    500       {ECO:0000244|PDB:5A9F}.
FT   HELIX       501    509       {ECO:0000244|PDB:5AGA}.
FT   HELIX       529    540       {ECO:0000244|PDB:5AGA}.
FT   HELIX       547    556       {ECO:0000244|PDB:5AGA}.
FT   TURN        559    562       {ECO:0000244|PDB:5AGA}.
FT   HELIX       581    591       {ECO:0000244|PDB:5AGA}.
FT   STRAND      594    598       {ECO:0000244|PDB:5AGA}.
FT   STRAND      607    611       {ECO:0000244|PDB:5AGA}.
FT   HELIX       613    620       {ECO:0000244|PDB:5AGA}.
FT   HELIX       625    638       {ECO:0000244|PDB:5AGA}.
FT   STRAND      645    647       {ECO:0000244|PDB:5AGA}.
FT   HELIX       648    653       {ECO:0000244|PDB:5AGA}.
FT   HELIX       666    674       {ECO:0000244|PDB:5AGA}.
FT   HELIX       678    687       {ECO:0000244|PDB:5AGA}.
FT   HELIX       691    698       {ECO:0000244|PDB:5AGA}.
FT   TURN        708    711       {ECO:0000244|PDB:5AGA}.
FT   HELIX       712    728       {ECO:0000244|PDB:5AGA}.
FT   TURN        729    731       {ECO:0000244|PDB:5AGA}.
FT   HELIX       734    741       {ECO:0000244|PDB:5AGA}.
FT   HELIX       745    768       {ECO:0000244|PDB:5AGA}.
FT   HELIX       772    778       {ECO:0000244|PDB:5AGA}.
FT   HELIX       781    787       {ECO:0000244|PDB:5AGA}.
FT   HELIX       791    794       {ECO:0000244|PDB:5AGA}.
FT   HELIX       796    798       {ECO:0000244|PDB:5AGA}.
FT   HELIX       804    811       {ECO:0000244|PDB:5AGA}.
FT   TURN        812    814       {ECO:0000244|PDB:5AGA}.
FT   HELIX       818    822       {ECO:0000244|PDB:5AGA}.
FT   HELIX       826    834       {ECO:0000244|PDB:5AGA}.
FT   STRAND      840    842       {ECO:0000244|PDB:5AGA}.
FT   STRAND      856    858       {ECO:0000244|PDB:5A9F}.
FT   HELIX       872    889       {ECO:0000244|PDB:5AGA}.
SQ   SEQUENCE   2590 AA;  289619 MW;  F5550BED2DAD8013 CRC64;
     MNLLRRSGKR RRSESGSDSF SGSGGDSSAS PQFLSGSVLS PPPGLGRCLK AAAAGECKPT
     VPDYERDKLL LANWGLPKAV LEKYHSFGVK KMFEWQAECL LLGQVLEGKN LVYSAPTSAG
     KTLVAELLIL KRVLEMRKKA LFILPFVSVA KEKKYYLQSL FQEVGIKVDG YMGSTSPSRH
     FSSLDIAVCT IERANGLINR LIEENKMDLL GMVVVDELHM LGDSHRGYLL ELLLTKICYI
     TRKSASCQAD LASSLSNAVQ IVGMSATLPN LELVASWLNA ELYHTDFRPV PLLESVKVGN
     SIYDSSMKLV REFEPMLQVK GDEDHVVSLC YETICDNHSV LLFCPSKKWC EKLADIIARE
     FYNLHHQAEG LVKPSECPPV ILEQKELLEV MDQLRRLPSG LDSVLQKTVP WGVAFHHAGL
     TFEERDIIEG AFRQGLIRVL AATSTLSSGV NLPARRVIIR TPIFGGRPLD ILTYKQMVGR
     AGRKGVDTVG ESILICKNSE KSKGIALLQG SLKPVRSCLQ RREGEEVTGS MIRAILEIIV
     GGVASTSQDM HTYAACTFLA ASMKEGKQGI QRNQESVQLG AIEACVMWLL ENEFIQSTEA
     SDGTEGKVYH PTHLGSATLS SSLSPADTLD IFADLQRAMK GFVLENDLHI LYLVTPMFED
     WTTIDWYRFF CLWEKLPTSM KRVAELVGVE EGFLARCVKG KVVARTERQH RQMAIHKRFF
     TSLVLLDLIS EVPLREINQK YGCNRGQIQS LQQSAAVYAG MITVFSNRLG WHNMELLLSQ
     FQKRLTFGIQ RELCDLVRVS LLNAQRARVL YASGFHTVAD LARANIVEVE VILKNAVPFK
     SARKAVDEEE EAVEERRNMR TIWVTGRKGL TEREAAALIV EEARMILQQD LVEMGVQWNP
     CALLHSSTCS LTHSESEVKE HTFISQTKSS YKKLTSKNKS NTIFSDSYIK HSPNIVQDLN
     KSREHTSSFN CNFQNGNQEH QTCSIFRARK RASLDINKEK PGASQNEGKT SDKKVVQTFS
     QKTKKAPLNF NSEKMSRSFR SWKRRKHLKR SRDSSPLKDS GACRIHLQGQ TLSNPSLCED
     PFTLDEKKTE FRNSGPFAKN VSLSGKEKDN KTSFPLQIKQ NCSWNITLTN DNFVEHIVTG
     SQSKNVTCQA TSVVSEKGRG VAVEAEKINE VLIQNGSKNQ NVYMKHHDIH PINQYLRKQS
     HEQTSTITKQ KNIIERQMPC EAVSSYINRD SNVTINCERI KLNTEENKPS HFQALGDDIS
     RTVIPSEVLP SAGAFSKSEG QHENFLNISR LQEKTGTYTT NKTKNNHVSD LGLVLCDFED
     SFYLDTQSEK IIQQMATENA KLGAKDTNLA AGIMQKSLVQ QNSMNSFQKE CHIPFPAEQH
     PLGATKIDHL DLKTVGTMKQ SSDSHGVDIL TPESPIFHSP ILLEENGLFL KKNEVSVTDS
     QLNSFLQGYQ TQETVKPVIL LIPQKRTPTG VEGECLPVPE TSLNMSDSLL FDSFSDDYLV
     KEQLPDMQMK EPLPSEVTSN HFSDSLCLQE DLIKKSNVNE NQDTHQQLTC SNDESIIFSE
     MDSVQMVEAL DNVDIFPVQE KNHTVVSPRA LELSDPVLDE HHQGDQDGGD QDERAEKSKL
     TGTRQNHSFI WSGASFDLSP GLQRILDKVS SPLENEKLKS MTINFSSLNR KNTELNEEQE
     VISNLETKQV QGISFSSNNE VKSKIEMLEN NANHDETSSL LPRKESNIVD DNGLIPPTPI
     PTSASKLTFP GILETPVNPW KTNNVLQPGE SYLFGSPSDI KNHDLSPGSR NGFKDNSPIS
     DTSFSLQLSQ DGLQLTPASS SSESLSIIDV ASDQNLFQTF IKEWRCKKRF SISLACEKIR
     SLTSSKTATI GSRFKQASSP QEIPIRDDGF PIKGCDDTLV VGLAVCWGGR DAYYFSLQKE
     QKHSEISASL VPPSLDPSLT LKDRMWYLQS CLRKESDKEC SVVIYDFIQS YKILLLSCGI
     SLEQSYEDPK VACWLLDPDS QEPTLHSIVT SFLPHELPLL EGMETSQGIQ SLGLNAGSEH
     SGRYRASVES ILIFNSMNQL NSLLQKENLQ DVFRKVEMPS QYCLALLELN GIGFSTAECE
     SQKHIMQAKL DAIETQAYQL AGHSFSFTSS DDIAEVLFLE LKLPPNREMK NQGSKKTLGS
     TRRGIDNGRK LRLGRQFSTS KDVLNKLKAL HPLPGLILEW RRITNAITKV VFPLQREKCL
     NPFLGMERIY PVSQSHTATG RITFTEPNIQ NVPRDFEIKM PTLVGESPPS QAVGKGLLPM
     GRGKYKKGFS VNPRCQAQME ERAADRGMPF SISMRHAFVP FPGGSILAAD YSQLELRILA
     HLSHDRRLIQ VLNTGADVFR SIAAEWKMIE PESVGDDLRQ QAKQICYGII YGMGAKSLGE
     QMGIKENDAA CYIDSFKSRY TGINQFMTET VKNCKRDGFV QTILGRRRYL PGIKDNNPYR
     KAHAERQAIN TIVQGSAADI VKIATVNIQK QLETFHSTFK SHGHREGMLQ SDQTGLSRKR
     KLQGMFCPIR GGFFILQLHD ELLYEVAEED VVQVAQIVKN EMESAVKLSV KLKVKVKIGA
     SWGELKDFDV
//
